赛诺菲第二季度利润不及预期，股价下跌超2%

英为财情

2025/07/31

Investing.com - 赛诺菲(Sanofi) (EPA:SASY)周四股价下跌超过2%，此前这家制药和医疗保健公司公布的第二季度利润低于预期，尽管销售额超过预测，但运营支出上升对利润率造成压力。这家法国公司公布的业务每股收益为1.59欧元，低于1.65欧元的一致预期。业务营业收入同比下降2%至24.6亿欧元，低于分析师预测的25.8亿欧元。收入增长6%至99.9亿欧元，超过97.9亿欧元...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2555888078"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2555888078\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2555888078?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-07-31 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2555888078","market":"hk","top_or_hot":-1,"title":"赛诺菲第二季度利润不及预期，股价下跌超2%","media":"英为财情","content":"<div>\n<p>Investing.com - 赛诺菲(Sanofi) (EPA:SASY)周四股价下跌超过2%，此前这家制药和医疗保健公司公布的第二季度利润低于预期，尽管销售额超过预测，但运营支出上升对利润率造成压力。这家法国公司公布的业务每股收益为1.59欧元，低于1.65欧元的一致预期。业务营业收入同比下降2%至24.6亿欧元，低于分析师预测的25.8亿欧元。收入增长6%至99.9亿欧元，超过97.9亿欧元...</p>\n\n<a href=\"https://cn.investing.com/news/earnings/article-2912354\">网页链接</a>\n\n</div>\n","source":"investing_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>赛诺菲第二季度利润不及预期，股价下跌超2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n赛诺菲第二季度利润不及预期，股价下跌超2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-31 16:44 北京时间&nbsp;&nbsp;&nbsp;<a href=https://cn.investing.com/news/earnings/article-2912354><strong>英为财情</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing.com - 赛诺菲(Sanofi) (EPA:SASY)周四股价下跌超过2%，此前这家制药和医疗保健公司公布的第二季度利润低于预期，尽管销售额超过预测，但运营支出上升对利润率造成压力。这家法国公司公布的业务每股收益为1.59欧元，低于1.65欧元的一致预期。业务营业收入同比下降2%至24.6亿欧元，低于分析师预测的25.8亿欧元。收入增长6%至99.9亿欧元，超过97.9亿欧元...</p>\n\n<a href=\"https://cn.investing.com/news/earnings/article-2912354\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1974910355.USD","symbol_name":"Allianz Thematica Cl AMg DIS USD","start_time":0,"source_url":"https://cn.investing.com/news/earnings/article-2912354","article_id":"2555888078","we_media_id":null,"thumbnails":[],"rights":{"source":"investing_news","url":"https://cn.investing.com/news/earnings/article-2912354","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555888078","pubTimestamp":1753951440,"columns":[{"name":"行业数据","id":30,"label_key":"dataReport"}],"sourceInfo":{"source_id":"investing_news","name":"英为财情新闻"},"weMediaInfo":null,"summary":"Investing.com - 赛诺菲 周四股价下跌超过2%，此前这家制药和医疗保健公司公布的第二季度利润低于预期，尽管销售额超过预测，但运营支出上升对利润率造成压力。流感疫苗带来1.41亿欧元收入，增长23%。赛诺菲提高了全年销售增长指引，按固定汇率计算预计为高个位数增长，高于此前的中高个位数范围。赛诺菲表示其有效税率保持基本稳定，2024年为19.8%，与19.9%的一致预期相符。","collect":0,"end_time":0,"defaultTopTitle":"investing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","REGN":"再生元制药公司","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0058720904.USD":"联博国际健康护理基金A","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","BK4585":"ETF&股票定投概念","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","BK4139":"生物科技","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1917777945.USD":"安联专题基金Cl AT Acc","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","BK4588":"碎股","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)"},"translate_title":"Sanofi Stock Drops More than 2% as Q2 Profit Misses Estimates","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1},"content_text":"Investing.com - 赛诺菲(Sanofi) (EPA:SASY)周四股价下跌超过2%，此前这家制药和医疗保健公司公布的第二季度利润低于预期，尽管销售额超过预测，但运营支出上升对利润率造成压力。这家法国公司公布的业务每股收益为1.59欧元，低于1.65欧元的一致预期。业务营业收入同比下降2%至24.6亿欧元，低于分析师预测的25.8亿欧元。收入增长6%至99.9亿欧元，超过97.9亿欧元的平均预期。增长主要由Dupixent、Altuviiio和包括Beyfortus在内的疫苗驱动。Dupixent销售额增长16%至38.3亿欧元，比一致预期高出2%，尽管在中国受到国家医保药品目录更新的一些压力。Altuviiio报告增长84%至2.91亿欧元，比预期高出16%。疫苗销售额增长6%至12.1亿欧元，比预期高出5%，这得益于Beyfortus收入的大幅增长和季末流感疫苗需求。Beyfortus销售额达到7200万欧元，高于一年前的1800万欧元。流感疫苗带来1.41亿欧元收入，增长23%。总收入为107.4亿欧元，高于一年前的101.6亿欧元。调整后毛利润增长8%至77.4亿欧元，毛利率从76%提高到77.5%。研发支出增长15%至19.1亿欧元。销售和一般成本增长4%至22.8亿欧元。其他营业收入增长37%至11.2亿欧元，部分原因是向Regeneron (NASDAQ:REGN)支付的单克隆抗体合作伙伴关系利润分成款项。业务净收入下降1%至19.4亿欧元。赛诺菲提高了全年销售增长指引，按固定汇率计算预计为高个位数增长，高于此前的中高个位数范围。然而，公司指出外汇影响将扩大至-4%，这意味着全年销售额在416亿欧元至432亿欧元之间，低于436亿欧元的一致预期。公司现预计2025年业务每股收益在7.56欧元至7.70欧元之间，基于6%的外汇影响，并包括新收购业务的成本。一致预期为7.97欧元。赛诺菲表示其有效税率保持基本稳定，2024年为19.8%，与19.9%的一致预期相符。\n本文由人工智能协助翻译。更多信息，请参见我们的使用条款。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}